Nivolumab

ATC L01FF01 · 11 markets · 58 records

Nivolumab 11 markets · 58 records Forms

GB 11 records · 6 strengths

100 mg/10 mLinjectionNivolumab BMS 40mg/4ml concentrate for solution for infusion vials+1Opdivo 40mg/4ml concentrate for solution for infusion vials also in AU·CN
40 mg/4 mLinjectionNivolumab BMS 40mg/4ml concentrate for solution for infusion vials+1Opdivo 40mg/4ml concentrate for solution for infusion vials also in AU·CN
240 mg/20 mLinjectionOpdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vials also in AU
600 mg/5 mLinjectionOpdivo 600mg/5ml solution for injection vials
240 mg/24 mLinjectionOpdivo 40mg/4ml concentrate for solution for infusion vials
120 mg/12 mLinjectionOpdivo 40mg/4ml concentrate for solution for infusion vials

AU 11 records · 9 strengths

100 mg/10 mLinjectionOPDIVO also in GB·CN
40 mg/4 mLinjectionOPDIVO also in GB·CN
240 mg/20 mLinjectionOPDUALAG also in GB
255.6 mginjectionOPDUALAG nivolumab 240mg and relatlimab 80mg in 20mL concentrate solution for IV infusion vial unknown
250 mginjectionOPDIVO nivolumab 240 mg in 24 mL (10 mg/mL) concentrate solution for IV infusion vial unknown
120 mg/mLinjectionOPDIVO SC nivolumab 600 mg in 5 mL (120 mg/mL) solution for injection vial unknown
107 mginjectionOPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial unknown
47 mginjectionOPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial unknown

Records without a stated strength · 1 OPDIVO、OPDIVO SC、OPDUALAG

ES 8 records · 1 strengths

10 mg/1 mLinjectionOPDIVO

US 7 records · 3 strengths

10 mginjectionOPDIVO also in TW
120 mginjectionOPDIVO QVANTIG
12 mginjectionOPDUALAG

CA 5 records · 3 strengths

120 mgliquidOPDIVO SC
12 mg/1 mLliquidOPDUALAG
10 mgliquidOPDIVO

HK 3 records · 1 strengths

Records without a stated strength · 1 OPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML

SG 2 records · 2 strengths

10 mg/mLinjectionOPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 10 MG/ML

Records without a stated strength · 1 OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG

CN 2 records · 2 strengths

100 mg/10 mLinjection欧狄沃纳武利尤单抗 also in GB·AU
40 mg/4 mLinjection欧狄沃纳武利尤单抗 also in GB·AU

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 OPDIVO、OPDUALAG

MX 1 records · 1 strengths

Records without a stated strength · 1 OPDIVO SC

TW 1 records · 1 strengths

10 mginjectionOPDIVO (nivolumab) Injection 10mg/mL+1保疾伏 also in US

Also called: 纳武单抗 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.